Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.

Abstract excerpt

Very long acyl-CoA dehydrogenase (VLCAD) deficiency is a genetic pediatric disorder presenting with a spectrum of phenotypes that remains for the most part untreatable. Here, we present a novel strategy for the correction of VLCAD deficiency by increasing mutant VLCAD enzymatic activity. Treatment of VLCAD-deficient fibroblasts, which express distinct mutant VLCAD protein and exhibit deficient fatty acid...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acetylcysteine
• Share to Acyl-CoA Dehydrogenase